One-Day Versus Three-Day Dexamethasone with NK1RA for Patients Receiving Carboplatin and Moderate Emetogenic Chemotherapy: A Network Meta-analysis

BACKGROUND: The dexamethasone (DEX)-sparing strategy, which limits administration of DEX to day one, is reportedly non-inferior to conventional antiemetic regimens comprising multiple-day DEX. However, the usefulness of the DEX-sparing strategy in triplet antiemetic prophylaxis (neurokinin-1 recepto...

Descripción completa

Detalles Bibliográficos
Autores principales: Watanabe, Daichi, Iihara, Hirotoshi, Fujii, Hironori, Makiyama, Akitaka, Nishida, Shohei, Suzuki, Akio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Symptom Management and Supportive Care
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9177112/
https://www.ncbi.nlm.nih.gov/pubmed/35427418
http://dx.doi.org/10.1093/oncolo/oyac060

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9177112/
https://www.ncbi.nlm.nih.gov/pubmed/35427418
http://dx.doi.org/10.1093/oncolo/oyac060

Ejemplares similares